Home Newsfeeds Barclays Maintains Equal-Weight on DexCom, Raises Price Target to $110

Barclays Maintains Equal-Weight on DexCom, Raises Price Target to $110

Barclays analyst Matt Miksic maintains DexCom (NASDAQ:DXCM) with a Equal-Weight and raises the price target from $103 to $110.

byBenzinga Newsdesk

February 13, 2023

1 minute read

Barclays analyst Matt Miksic maintains DexCom (NASDAQ:DXCM) with a Equal-Weight and raises the price target from $103 to $110.

Analyst Ratings

What 10 Analyst Ratings Have To Say About Waste Management

By Benzinga Insights

October 17, 8:00 AM

Within the last quarter, Waste Management (NYSE:WM) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

Cathie Wood Buys Nearly $7M In This Sapped Bitcoin-Linked Stock — Also Picks Up Shares In CareDx

By Bhavik Nair

September 14, 9:12 PM

Cathie Wood-led Ark Investment Management has bought over 100,000 shares of Jack Dorsey’s Block Inc (NYSE: SQ), valued at over $6.9 million based on Wednesday’s closing price.

ARKG

CVR Partners Files Form 10-K Annual Report For Fiscal Year Ended December 31, 2022

By Happy Mohamed

February 22, 6:19 PM

CVR Partners, LP (NYSE:UAN), a manufacturer of ammonia and urea ammonium nitrate ("UAN") solution fertilizer products, today announced that it has filed its annual report on Form 10-K for the fiscal year ended

UAN